Supplement to the Nomination Committee’s proposal to the Extraordinary General Meeting of Studsvik AB

Studsvik AB's Nomination Committee has updated its proposal for the Extraordinary General Meeting on January 23, 2026, to increase the number of board members from seven to eight and to appoint Julia Pyke and Adam Rodman as new directors. Pyke, currently Co-Managing Director of the Sizewell C project that secured over £38 billion in funding with a positive final investment decision in July 2025, brings large-infrastructure and community-engagement expertise; Rodman, founder and CIO of Segra Capital and former partner at Corriente Advisors, brings nuclear-focused investment and industry research experience and holds dual US–Swedish citizenship. The committee proposes board remuneration of SEK 236,250 pro rata plus SEK 50,000 in committee fees; the appointments bolster Studsvik's nuclear and investment credentials but are unlikely to produce a material market move.

Analysis

Market structure: The Studsvik board additions increase sector credibility for nuclear services and signal better access to project-level intelligence and capital markets; immediate beneficiaries are nuclear service providers (BWXT, specialist engineering) and fuel suppliers/miners (URA, CCJ, NXE) as pipeline visibility increases. Losers are marginal renewable developers and contractors exposed to fixed-price EPC risk in large nuclear projects where engineering firms capture more value; expect selective pricing power for specialized component suppliers, not broad contractor leverage.

Risk assessment: Near-term (days–weeks) impact is limited to sentiment and small-cap rerating; short-term (3–12 months) hinges on contract awards, financing milestones and UX/spot uranium moves; long-term (1–5 years) depends on FIDs and supply-chain capacity (fabrication, enrichment). Tail risks: political reversals, major cost-overruns, or a major nuclear incident could erase multi-year upside; watch thresholds—if spot U3O8 drops >20% from current levels or fails to rise >10% in 3–6 months, mining earnings upgrades stall. Hidden dependencies include government guarantees, local permitting and enrichment throughput; catalysts are UK/US FIDs, government loan guarantees, and uranium spot crossing ~$100/lb.

Trade implications: Favor small, staged long exposure to uranium and nuclear services while using options to limit downside—target 2–4% portfolio weight in URA/CCJ + 1–2% in BWXT-like services over 6–18 months; use 6–12 month call-spreads to leverage potential re-rating. Pair trades: long nuclear services (BWXT) vs short leveraged EPC/contractor names in the UK (select contractors) to capture margin divergence; hedge FX risk (USD/SEK) for Swedish names if trading internationally. Entry: initiate tranches now and on post-EGM clarity (Jan 24–Feb 28, 2026); take profits at +30–40% or if uranium >$100/lb, cut losses at -20% per position.

Contrarian angles: The market may underprice execution risk—board appointments are credibility signals, not revenue guarantees—so avoid large single-name bets on Studsvik without contract wins. Conversely, miners remain under-owned; if multiple FIDs occur within 12 months, miners/URA could re-rate sharply (30%+). Historical parallels (post-2000 uranium cycles) show multi-year rallies after policy inflection points but punctuated by long lead times—position sizing and option structures should reflect that friction. Watch for unintended consequences: rapid project acceleration can trigger component bottlenecks and inflation, compressing EPC margins and benefiting specialized fabricators instead.

Key Decisions for Investors

• If Studsvik AB is in the investable universe, establish a small 0.5–1.0% long position after the EGM passes (post Jan 23, 2026); target +25–35% over 6–12 months on rerating from board/contract wins, stop-loss 25%.
• Allocate 2.0–3.0% portfolio weight to uranium exposure via URA (ETF) or a 1.5–2.0% split into CCJ/NXE over 6–18 months; trim half if uranium spot fails to rise by ≥10% within 90 days, take profits if spot >$100/lb or position +30–40%.
• Use options to limit downside: buy 9–12 month call spreads on CCJ (buy ~25% OTM, sell ~60% OTM) sized to 0.5–1.0% of portfolio or buy a 12‑month URA call-spread (20–40% OTM) to capture upside while capping premium.
• Implement a pair trade: long 1.0% BWXT (nuclear services) vs short 1.0% exposure to a leveraged UK EPC/contractor (e.g., Balfour Beatty LSE: BBY) to capture margin/share gains; exit on a 20% relative move or after key UK contract awards within 6–12 months.
• Reduce 1–3% exposure to high‑multiple, pure‑play renewable developers over the next quarter and re-allocate into nuclear services/miners if two or more major FIDs are announced in the next 6–12 months (monitor UK/US government announcements and uranium spot price as primary triggers).